Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Study Comparing Intensity Modulated Planning Versus 3-Dimensional Planning for Accelerated Partial Breast Radiotherapy

NCT01185132 is registered in ClinicalTrials.gov with Rocky Mountain Cancer Centers as lead sponsor.

NCT NCT01185132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01185132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Study Comparing Intensity Modulated Planning Versus 3-Dimensional Planning for Accelerated Partial Breast Radiotherapy
Lead sponsor
Rocky Mountain Cancer Centers
Phase
Phase 3
Overall status
Recruiting
Start date
July 31, 2009
Completion date
July 31, 2028
Enrollment
660 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer